One vial contains 75 IU of lutropin alfa*.
Luveris 75IU powder and solvent for solution for injection in association with a follicle stimulating hormone (FSH) preparation is recommended for the stimulation of follicular development in adult women with severe luteinising hormone (LH) and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/L.
Luveris is intended for subcutaneous use. The first injection of Luveris should be performed under direct medical supervision. The powder should be reconstituted immediately prior to use with the solvent provided. Self-administration of this medicinal product should only be performed by patients who are well-motivated, adequately trained and with access to expert advice.